Baldwin Brothers LLC Recursion Pharmaceuticals, Inc. Transaction History

Baldwin Brothers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$6.59 - $15.86 $12,086 - $29,087	1,834 Added 33.33%	7,336 $56,000
Q3 2022 Oct 14, 2022	BUY	$7.83 - $13.6 $21,540 - $37,413	2,751 Added 100.0%	5,502 $59,000
Q2 2022 Jul 18, 2022	BUY	$5.04 - $9.26 $13,865 - $25,474	2,751 New	2,751 $22,000
Q1 2022 Apr 13, 2022	SELL	$6.16 - $18.03 $16,946 - $49,600	-2,751 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$16.14 - $21.86 $44,401 - $60,136	2,751 New	2,751 $47,000

291

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.32B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

Stay updated on Baldwin Brothers LLC with notifications on news.